InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
19
T+90 hit rate
40%
T+90 mean return
+21.2%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Levine Mark S., Executive. Officer active across 2 companies, notably Flexion Therapeutics Inc. In total, 26 disclosures have been recorded. Split: 0 buy · 19 sells. Total volume traded: €1.9m. History available since 19 July 2021. The latest transaction was filed on 20 November 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations26 total
3,650 shares@ US$25.454.7% of flowCommon StockSEC:0001764013-24-000196:0
4,361 shares@ US$29.536.4% of flowCommon StockSEC:0001764013-24-000180:0
2,860 shares@ US$28.794.1% of flowCommon StockSEC:0001764013-24-000172:0
3,164 shares@ US$31.844.8% of flowCommon StockSEC:0001764013-24-000160:0
4,015 shares@ US$27.765.5% of flowCommon StockSEC:0001764013-24-000141:0
2,358 shares@ US$29.643.4% of flowCommon StockSEC:0001764013-24-000137:0
3,242 shares@ US$29.654.8% of flowCommon StockSEC:0001764013-24-000095:0
3,963 shares@ US$28.905.7% of flowCommon StockSEC:0001764013-24-000085:0
7,602 shares@ US$28.8011.0% of flowCommon StockSEC:0001764013-24-000083:0
54,978 shares0Common StockSEC:0001764013-24-000055:0
2,134 shares@ US$36.153.8% of flowCommon StockSEC:0001764013-24-000040:0
2,981 shares@ US$37.915.6% of flowCommon StockSEC:0001764013-24-000018:0
3,128 shares@ US$32.755.0% of flowCommon StockSEC:0001764013-23-000137:0
4,107 shares@ US$34.667.2% of flowCommon StockSEC:0001764013-23-000125:0
12,285 shares@ US$20.3012.4% of flowCommon StockSEC:0001764013-23-000105:0
3,917 shares@ US$21.634.1% of flowCommon StockSEC:0001764013-23-000084:0
2,633 shares@ US$16.292.1% of flowCommon StockSEC:0001764013-23-000059:0
87,664 shares0Common StockSEC:0001764013-23-000041:0
10,156 shares@ US$18.519.2% of flowCommon StockSEC:0001764013-23-000015:0
112,816 shares0Common StockSEC:0001764013-22-000107:0
143,000 shares0Common StockSEC:0001764013-22-000027:0
143,000 shares0Common StockSEC:0001764013-22-000027
133,486 shares@ US$8.5048.9% of flowCommon StockSEC:0001209191-21-065712:0
133,486 shares@ US$8.5048.9% of flowCommon StockSEC:0001209191-21-065712
3,945 shares@ US$6.451.1% of flowCommon StockSEC:0001209191-21-047502:0
25 of 26 declarations
About Levine Mark S.
Mark S. Levine is General Counsel and Chief Legal Officer at Flexion Therapeutics Inc and Immunovant, Inc. He oversees the legal affairs of the companies and ensures compliance with applicable regulations.
